Literature DB >> 10446914

Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands and RetroNectin culture.

L Murray1, K Luens, R Tushinski, L Jin, M Burton, J Chen, S Forestell, B Hill.   

Abstract

We have investigated the ability of several cytokine combinations to improve retrovirus-mediated transduction of human primitive hematopoietic progenitors (PHPs) from mobilized peripheral blood (MPB). Retroviral infection of CD34+ cells was performed by culture on fibronectin fragment CH-296 (RetroNectin, RN), using the truncated human nerve growth factor receptor (NGFR) as the transgene reporter. Transgene expression among progeny of PHPs was assayed by FACS analysis after long-term stromal culture (LTC). Transgene delivery to PHPs was assessed by PCR of individual stromal culture-derived methylcellulose colonies (LTC-CFCs). Compared with interleukin 3 (IL-3), IL-6, and leukemia inhibitory factor (LIF), the combination of thrombopoietin (TPO), Flt3 ligand (FL), and Kit ligand (KL) effected a 73-fold increase in NGFR expression among CD34+ cells (to 14%) and a 14-fold increase in NGFR expression among total cells (to 10%) after LTC. In addition, a 2.4-fold increase in neo gene marking of LTC-CFCs was observed. A preclinical study comparing the effect of high-speed centrifugation ("spinoculation") or culture on RN during exposure to retroviral particles in teflon cell culture bags showed no difference in the efficiency of transduction of PHPs between these two methods.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446914     DOI: 10.1089/10430349950017428

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  6 in total

1.  Optimized transduction of canine paediatric CD34(+) cells using an MSCV-based bicistronic vector.

Authors:  S E Suter; T A Gouthro; P A McSweeney; R A Nash; M E Haskins; P J Felsburg; P S Henthorn
Journal:  Vet Res Commun       Date:  2006-11       Impact factor: 2.459

2.  Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes.

Authors:  M Lee Lucas; Nancy E Seidel; Christopher D Porada; John G Quigley; Stacie M Anderson; Harry L Malech; Janis L Abkowitz; Esmail D Zanjani; David M Bodine
Journal:  Blood       Date:  2005-03-17       Impact factor: 22.113

3.  Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cells.

Authors:  Peter Ebeling; P Bach; U Sorg; A Schneider; T Trarbach; D Dilloo; H Hanenberg; S Niesert; S Seeber; T Moritz; M Flasshove
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-20       Impact factor: 4.553

4.  Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trials.

Authors:  Tulin Budak-Alpdogan; Isabelle Rivière
Journal:  Methods Mol Biol       Date:  2009

5.  Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes.

Authors:  Claudia Piovan; Virna Marin; Cinzia Scavullo; Stefano Corna; Erica Giuliani; Sergio Bossi; Anne Galy; David Fenard; Claudio Bordignon; Gian Paolo Rizzardi; Chiara Bovolenta
Journal:  Mol Ther Methods Clin Dev       Date:  2017-03-08       Impact factor: 6.698

6.  High efficiency closed-system gene transfer using automated spinoculation.

Authors:  Victoria Ann Remley; Jianjian Jin; Sarmila Sarkar; Larry Moses; Michaela Prochazkova; Yihua Cai; Lipei Shao; Hui Liu; Tatyana Fuksenko; Ping Jin; David F Stroncek; Steven L Highfill
Journal:  J Transl Med       Date:  2021-11-24       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.